Takeda Gains Access To European OTC Market With $13.7B Nycomed Buy
This article was originally published in The Tan Sheet
Executive Summary
Japanese pharma giant Takeda Pharmaceuticals Co. Ltd. gains access to the European OTC market with its $13.7 billion purchase of Swiss firm Nycomed AS.